Open AccessThe effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
Author(s) -
Sellers Cortlandt M.,
Uhlig Johannes,
Ludwig Johannes M.,
Pollak Jeffrey S.,
Taddei Tamar H.,
Stein Stacey M.,
Lim Joseph K.,
Kim Hyun S.
Publication year - 2021
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.3573
Subject(s) - hepatocellular carcinoma , medicine , hazard ratio , gastroenterology , proportional hazards model , viral hepatitis , hepatitis c , biomarker , viral load , immunology , confidence interval , human immunodeficiency virus (hiv) , biology , biochemistry
Abstract Background Inflammation and the immune system significantly impact the development, progression, and treatment response of hepatocellular carcinoma (HCC). This retrospective study investigated the neutrophil‐to‐lymphocyte ratio (NLR) as a prognostic biomarker in Western patients with HCC in the setting of chronic viral hepatitis. Methods Patients diagnosed with HCC from 2005 to 2016 were selected from a tertiary care institution. NLR was calculated within 30 days prior to treatment and dichotomized at the median. Kaplan–Meier overall survival (OS) curves and Cox hazard proportional models were utilized. Tumor and liver reserve parameters were included in multivariable analyses (MVA). Results A total of 581 patients met inclusion criteria (median age 61.0 yr; 78.3% male; 66.3% Caucasian) with median OS = 34.9 mo. 371 patients (63.9%) had viral hepatitis, of which 350 had hepatitis C (94.3%). The low‐NLR group (